Chris Gemmiti

Dedicated to regenerative medicine / cell and gene therapy. Passion for early stage translation, development and commercialization. Thoughts are that of my own.

[Colin Barkan @cbarkmedia]

Fantastic breakaway glove save by Oliver Ames' Nolan Gemmiti vs. Duxbury last night in the MIAA State Tournament

@MHLbbiglive @OAHSHockey @Murray_Jack_

[Oliver Ames Hockey @OAHSHockey]

The boys skate to a strong victory over Foxboro 5-0. Goals by
🚨🚨🚨Lawson🎩
🚨Livingstone
🚨Tobin with his first varsity goal!
Nolan Gemmiti solid in net again with his first career varsity shutout!
@T_Mulherin @MassNZ @MassHSHockey @HockomockSports @R_Lanigan @OAHSTigersports

[AOF HOCKEY @AOF_Hockey]

Final from NH!!
NEW ENGLAND CHAMPIONS
#WINgedBeavers

[CRISPR Therapeutics @CRISPRTX]

Today, we announced our fourth quarter and full year earnings results. Read more about our recent highlights and outlook: https://t.co/4o5TeANGCS

[Oliver Ames Hockey Boosters @OAhockeybooster]

The OA Hockey community mourns the loss of former teammate to many, Dylan Quinn. We stand with Southeastern Regional / BP Hockey in honoring and remembering DQ’s young life taken much too soon.

[CRISPR Therapeutics @CRISPRTX]

CRISPR Therapeutics and Vertex are pleased to share that we completed our regulatory submissions for exa-cel for sickle cell disease and beta thalassemia in the EU and the UK in December 2022.

[Chris Gemmiti @ChrisGemmiti]

@DrPlattLab @NIH @nibib @Morehouse @CoulterBME @GeorgiaTech @gatechengineers @GT_BioE @ibbgatech @BlackInBME @BlkInEngineerng Awesome! Congrats, Manu!

[Adam Feuerstein ✡️ @adamfeuerstein]

Updated $VRTX $CRSP study results show a CRISPR treatment for blood diseases continues to benefit patients https://t.co/dpNVOPmZwG $BLUE

[Chris Gemmiti @ChrisGemmiti]

https://t.co/NnT6adMwnY

[CRISPR Therapeutics @CRISPRTX]

We’re at #ASH21 alongside experts in the #hematology field to learn from our peers and spread awareness as we continue our work to potentially treat #sicklecelldisease, #betathalassemia and #bloodcancers. If you’re attending the @ASH_hematology meeting, come by our booth #3323.

[Chris Gemmiti @ChrisGemmiti]

@GarciaLabGT Congrats!

[Boston Business Journal @BosBizJournal]

One of the scientific founders of CRISPR Therapeutics AG (Nasdaq: CRSP) is embarking on a mission to solve a longstanding problem in stem cell therapy: ensuring that the body does not mount an immune response to the foreign cells. https://t.co/e6yVwkNrbi

[CRISPR Therapeutics @CRISPRTX]

Did you know there are multiple ways to generate #CARTCells? Learn about the differences between autologous and allogeneic CAR T cells in our newest video: https://t.co/G3kWK6B5y7

[Chris Gemmiti @ChrisGemmiti]

@jrkelly @Ginkgo Incredible achievement, Jason - congrats! Looking forward to what's next ...

[Charles Gersbach @cgersbach]

We're very happy to see this published with the hope that others will be able to use these models to study function and regulation of their favorite genes and noncoding elements. Mice are available at Jax: https://t.co/9ZqSHwaIsg https://t.co/8flLbT9MGj

[CRISPR Therapeutics @CRISPRTX]

$CRSP and @CapsidaBio are excited to announce a strategic collaboration to develop in vivo gene editing therapies for #ALS and #FriedreichsAtaxia (FA). Read more: https://t.co/dRdDUfrJz8

[Endpoints News @endpts]

On Tuesday, Vertex announced they would pay CRISPR Therapeutics $900 million cash to take an additional 10% of future sales from the gene editing therapy CTX001.

https://t.co/Te6wO0T65f

[CRISPR Therapeutics @CRISPRTX]

Today, $CRSP and @VertexPharma, announced that the companies have amended their collaboration agreement for our investigational CRISPR/Cas9 gene-editing program for severe hemoglobinopathies. Learn more here: https://t.co/3pw98Bm7Qh

[John Carroll @JohnCendpts]

Ver­tex pays CRISPR $900M to take con­trol of sick­le cell part­ner­ship, bet­ting they can beat blue­bird to mar­ket
https://t.co/I0sVOH6AZa

[Chris Gemmiti @ChrisGemmiti]

CRISPR Therapeutics Presents Preclinical Data at AACR 2021 Supporting CD70 Knockout as a Novel Approach to Increasing CAR-T Cell Function https://t.co/sblkP8zmE2